Omega Healthcare Reports $0.27 EPS, $0.82 AFFO per Share and Raises 2026 Guidance

Omega Healthcare reported Q3 2026 earnings of $0.27 per share and $0.82 AFFO per share, with revenue up to $340.6M from $311.6M YoY. The company raised its full-year AFFO guidance to $3.28–$3.30 per share. Omega completed new investments and saw improvements in operator metrics, including 82.7% occupancy.

Original reporting
Published Nov 3, 2026, 9:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 6:26 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Omega Healthcare Reports $0.27 EPS, $0.82 AFFO per Share and Raises 2026 Guidance — source image
Decision brief

The 30-second read

$OHIBullishMed
01

Why it matters

The key tradable catalyst is the raised 2026 Adjusted FFO guidance range, alongside improved occupancy and coverage metrics, which together affect forward cash-flow expectations for the REIT.

02

Market read

A raised 2026 AFFO outlook with operational improvements is likely to be the primary driver for positioning in OHI and peer REITs focused on senior housing and skilled nursing.

03

What to watch

Genesis bankruptcy sale mechanics (lease assumption/assignment and loan repayments) could carry integration or tenant-risk nuances not fully captured by headline AFFO guidance.

Relevance 8/10Novelty 8/10Timing: after-hours/late-day following the Q3 2026 results and 2026 guidance raise

Background

Omega Healthcare Investors reported Q3 2026 results and described ongoing investment activity, including U.S. senior housing/skilled nursing acquisitions and U.K. care home lease-structure shifts.

Company-level read

Ticker impact

$OHIBullishHigh confidence
Context

Omega Healthcare raised full-year 2026 Adjusted FFO guidance to $3.28–$3.30 per diluted share after reporting Q3 results and improved operator metrics.

Expected impact

Likely upward bias as the market reprices 2026 AFFO/cash-flow outlook following the guidance increase.

Evidence & confidence

The article is a primary earnings/guidance disclosure with specific raised AFFO range and operational improvements (occupancy and coverage), which typically drives REIT earnings power expectations.

Market effects

Supports sentiment for senior housing/skilled nursing REITs by signaling improved occupancy and lease-structure transitions (PACS/RIDEA) translating into better coverage.

Limited direct regional read-through beyond U.S. skilled nursing and U.K. care home operations.

Low; primarily company-specific within healthcare real estate.

Counterpoint

The guidance raise may already be partially anticipated; investors may focus on whether occupancy and coverage gains are sustainable versus driven by one-time lease transitions and bankruptcy-related assumptions.

Key entities

  • Omega Healthcare Investors Inc

    Reported Q3 2026 net income and Adjusted FFO, raised full-year 2026 Adjusted FFO guidance, and highlighted lease-structure transitions and improved operator metrics.

  • Genesis bankruptcy sale

    Finalized sale where Omega’s master lease was assumed and assigned to the buyer, and related loans were repaid.

Related articles

$OHIMed

What Omega Healthcare Investors (OHI) Said on Its Q3 Earnings Call

Omega Healthcare Investors (OHI) completed a Florida transition, adding 32 skilled nursing facilities to its PACS master lease at $58M annual rent, up $26.1M. The company paid a $90M termination fee and expects a $0.065 per share annualized FAD boost. OHI also converted 30 U.K. care homes to RIDEA structures, spending $48M. Q3 investments totaled $181M, with $946M post-quarter, including an $846M mortgage loan. OHI reported $1.5B in YTD investments and a strong pipeline.

$OHIMedAI 8/10

Omega Healthcare Investors: Q3 Earnings Snapshot

Omega Healthcare Investors (OHI) reported Q3 funds from operations of $262.1M, or 82 cents per share, beating analysts' estimates of 81 cents. Net income was $83.1M, or 27 cents per share, with revenue at $340.6M. The company expects full-year funds from operations between $3.28 and $3.30 per share.